Cited by 155Cell death mechanisms and regulationNF-κB Signaling PathwaysHepatocellular Carcinoma Treatment and Prognosis

RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer

Open access
Schneider, Anne T., Gautheron, Jérémie, Feoktistova, Maria, Roderburg, Christoph, Loosen, Sven H., Roy, Sanchari, Benz, Fabian, Schemmer, Peter +14 more·2017·Cancer Cell

Abstract

Receptor-interacting protein kinase 1 (RIPK1) represents an essential signaling node in cell death and inflammation. Ablation of Ripk1 in liver parenchymal cells (LPC) did not cause a spontaneous phenotype, but led to tumor necrosis factor (TNF)-dependent hepatocyte apoptosis and liver injury without affecting inducible nuclear factor κB (NF-κB) activation. Loss of Ripk1 induced the TNF-dependent proteasomal degradation of the E3-ligase, TNF receptor-associated factor 2 (TRAF2), in a kinase-independent manner, thereby activating caspase-8. Moreover, loss of both Ripk1 and Traf2 in LPC not only resulted in caspase-8 hyperactivation but also impaired NF-κB activation, promoting the spontaneous development of hepatocellular carcinoma. In line, low RIPK1 and TRAF2 expression in human HCCs was associated with an unfavorable prognosis, suggesting that RIPK1 collaborates with TRAF2 to inhibit murine and human hepatocarcinogenesis.

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2016.11.009

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schneider, A. T., Gautheron, J., Feoktistova, M., Roderburg, C., Loosen, S. H., Roy, S., Benz, F., Schemmer, P., Büchler, M. W., Nachbur, U., Neumann, U. P., Tolba, R., Luedde, M., Zucman-Rossi, J., Panayotova-Dimitrova, D., Leverkus, M., Preisinger, C., Tacke, F., Trautwein, C., Longerich, T., Vucur, M., & Luedde, T.
Affiliations
  • RWTH Aachen University (DE)
  • Heidelberg University (DE)
  • The University of Melbourne (AU)
  • University Hospital Schleswig-Holstein (DE)
Corresponding author
  • Vucur, Mihael
  • Luedde, Tom
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2017-01
Volume
31
Issue
1
Pages
94-109
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2564880418
Cited by
155
References
50
Citations by year
2025: 12 · 2024: 20 · 2023: 33 · 2022: 11 · 2021: 16 · 2020: 16 · 2019: 18 · 2018: 16 · 2017: 13
FWCI
8.14
Type
journal article
Language
en
Open access
Locations
  • Cancer Cell (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
Funders
  • Deutsche Krebshilfe (110885)
  • DFG (LU 1360/3-1, SFB-TRR57/P06, LO-1676-2/1)
  • IZKF
  • Ernst-Jung-Foundation Hamburg
  • RWTH Aachen university
  • National Center for Tumor Diseases Heidelberg
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
Keywords
RIPK1, TRAF2, hepatocellular carcinoma, hepatocarcinogenesis, caspase-8 activation, NF-κB activation, proteasomal degradation, E3 ubiquitin ligase, liver parenchymal cells, cancer prognosis, kinase-independent signaling
MeSH terms
Animals, Humans, Liver Neoplasms, Male, Mice, Inbred C57BL, Tumor Necrosis Factor-alpha, NF-kappa B, Hepatocytes, Proteasome Endopeptidase Complex, TNF Receptor-Associated Factor 2, Mice, Caspase 8, Receptor-Interacting Protein Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review